» Articles » PMID: 25435005

Therapeutic Effect of Human Umbilical Cord Mesenchymal Stem Cells Modified by Angiotensin-converting Enzyme 2 Gene on Bleomycin-induced Lung Fibrosis Injury

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2014 Dec 2
PMID 25435005
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to evaluate the therapeutic effects of human umbilical cord mesenchymal stem cells (uMSCs) in the presence of angiotensin‑converting enzyme 2 gene (ACE2; ACE2‑uMSCs) on bleomycin (BLM)‑induced lung injury and pulmonary fibrosis in mice. A total of 100 male C57BL/6 mice were divided at random into five groups (n=20) as follows: Control group, BLM group, ACE2 group, uMSC group and ACE2‑uMSC group. At 7, 14 and 28 days post‑treatment, the following parameters were evaluated in lung tissue: Oxidation indexes [malondialedehyde (MDA), superoxide dismutase (SOD), glutathione (GSH) and oxidized glutathione (GSSG)]; fibrosis factors [tumor necrosis factor (TNF)‑α, interferon (IFN)‑γ and transforming growth factor (TGF)‑β]; inflammatory cytokines [Interleukin (IL)‑1, IL‑2, IL‑6 and IL‑10]; ACE2 gene expression; hydroxyproline and collagen type 1 messenger RNA (mRNA) concentration; as well as matrix metalloproteinase (MMPs; 2 and 9) and tissue inhibitor of metalloproteinase (TIMP)1‑4 expression. ACE2‑uMSC injection following bleomycin pretreatment significantly alleviated lung injury in mice. In addition, treatment with ACE2‑uMSCs demonstrated a stronger therapeutic effect than ACE2‑ or uMSC treatment alone, indicated by decreased expression of MDA, GSSG, TNF‑α, IFN‑γ, TGF‑β, IL‑1, IL‑2, IL‑6, collagen type 1 mRNA, MMPs and TIMPs as well as hydroxyproline concentration, and upregulation of SOD, GSH and ACE2 and IL‑10. In conclusion, the results of the present study demonstrated that ACE2 and uMSCs had a synergistic therapeutic effect on bleomycin‑induced acute lung injury.

Citing Articles

Angiotensin-Converting Enzyme 2 Enhances Autophagy via the Consumption of miR-326 in a Mouse Model of Acute Lung Injury.

Lin X, Gao F Biochem Genet. 2025; .

PMID: 39869241 DOI: 10.1007/s10528-025-11040-3.


Manufacturing mesenchymal stromal cells in a microcarrier-microbioreactor platform can enhance cell yield and quality attributes: case study for acute respiratory distress syndrome.

Krupczak B, Farruggio C, Van Vliet K J Transl Med. 2024; 22(1):614.

PMID: 38956643 PMC: 11220991. DOI: 10.1186/s12967-024-05373-7.


The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS.

Santos C, Lopes-Pacheco M, English K, Rolandsson Enes S, Krasnodembskaya A, Rocco P Cells. 2024; 13(2).

PMID: 38247814 PMC: 10813908. DOI: 10.3390/cells13020122.


Boosting therapeutic efficacy of mesenchymal stem cells in pulmonary fibrosis: The role of genetic modification and preconditioning strategies.

Mehrabani M, Mohammadyar S, Rajizadeh M, Bejeshk M, Ahmadi B, Nematollahi M Iran J Basic Med Sci. 2023; 26(9):1001-1015.

PMID: 37605719 PMC: 10440137. DOI: 10.22038/IJBMS.2023.69023.15049.


Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases.

Lopes-Pacheco M, Rocco P Front Pharmacol. 2023; 14:1067422.

PMID: 37007034 PMC: 10062457. DOI: 10.3389/fphar.2023.1067422.


References
1.
Fong C, Gauthaman K, Cheyyatraivendran S, Lin H, Biswas A, Bongso A . Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo. J Cell Biochem. 2011; 113(2):658-68. DOI: 10.1002/jcb.23395. View

2.
Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, Kaibe M . Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension. 2006; 47(4):718-26. DOI: 10.1161/01.HYP.0000205833.89478.5b. View

3.
Imai Y, Kuba K, Penninger J . Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cell Mol Life Sci. 2007; 64(15):2006-12. PMC: 7079778. DOI: 10.1007/s00018-007-6228-6. View

4.
Uhal B, Li X, Xue A, Gao X, Abdul-Hafez A . Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis. Am J Physiol Lung Cell Mol Physiol. 2011; 301(3):L269-74. PMC: 3174737. DOI: 10.1152/ajplung.00222.2010. View

5.
Ortiz L, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N . Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A. 2003; 100(14):8407-11. PMC: 166242. DOI: 10.1073/pnas.1432929100. View